True or false Rocky: without these deals ACT would at best not be in clinical trials now and at worst (and more likely IMO) would be bankrupt. Not sure that you can hold something against a guy for something he as you put it "finished off" (meaning he didn't start it) in February when he took over in late-Dec. I guess we'll have to agree to disagree on Rabin's culpability in all of this and the extent to which his feet should be held to the fire. Clearly there have been ongoing financial issues with ACT for awhile now. As much as I'm not a fan of Rabin's, I think he's done a decent job since he took over. That doesn't mean I wouldn't like to see him back to only the CFO as soon as these Phase I/II trials are complete, but I don't think he deserves the criticism he's getting from some here from those pointing the finger squarely at him and calling for his head when the guy is basically playing the cards he was dealt (pun intended).
News 
Market Data 
Discover 
AI
